Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Addus HomeCareADUS +0.79%95 3-Year EBITDA Growth Rate is 18.60% as of Jun. 2026, which is 64% above its 10-year median of 11.35. GuruFocus rates ADUS with a GF Score™ of 95/100 and a GF Value™ of $124.14 (Fairly Valued). The stock has 4 warning signs investors should review. Among 527 Healthcare Providers & Services companies, Addus HomeCare ranks better than 64.33% on this metric.
During the past 12 months, Addus HomeCare's average EBITDA Per Share Growth Rate was 22.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 18.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 17.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 16.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Addus HomeCare was 22.20% per year. The lowest was -52.90% per year. And the median was 11.35% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Addus HomeCare 3-Year EBITDA Growth Rate Related Terms
ADUS vs MD, AVAH, SGRY: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Addus HomeCare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Addus HomeCare 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Addus HomeCare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Addus HomeCare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 18.60% mean?
Addus HomeCare (ADUS) has a 3-Year EBITDA Growth Rate of 18.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Addus HomeCare and its competitors. This is 64% above median its historical median of 11.35. According to the industry distribution chart, Addus HomeCare ranks #188 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 35.7%.
Is Addus HomeCare's 3-Year EBITDA Growth Rate too high?
Addus HomeCare's current 3-Year EBITDA Growth Rate of 18.60% is 64% above median its 10-year median of 11.35. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Addus HomeCare's value of 18.60% is 82.4% above this industry median. Based on the distribution chart, Addus HomeCare ranks #188 out of 527 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Addus HomeCare has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Addus HomeCare's 3-Year EBITDA Growth Rate compare to MD and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Addus HomeCare ranks #188 out of 527 companies for 3-Year EBITDA Growth Rate. This puts Addus HomeCare in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Addus HomeCare's value of 18.60% is 82.4% above this benchmark. While the company's 10-year median is 11.35 vs. the industry median of 10.20, Addus HomeCare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Addus HomeCare's current 3-Year EBITDA Growth Rate of 18.60% is 82.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Addus HomeCare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Addus HomeCare's current 3-Year EBITDA Growth Rate is 18.60%, which is 64% above median its own 10-year median of 11.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Addus HomeCare stock overvalued right now?
Based on GuruFocus' analysis, Addus HomeCare (ADUS) is currently considered Fairly Valued. The stock's GF Value™ is $124.14, compared to a current price of $119.68 — trading 3.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 18.60%, which is 64% above median its 10-year median of 11.35 and 82.4% above the Healthcare Providers & Services industry median of 10.20. Addus HomeCare's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Addus HomeCare (ADUS), the current 3-Year EBITDA Growth Rate is 18.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Addus HomeCare (ADUS) Overvalued in 2026?
Based on GuruFocus' analysis, Addus HomeCare stock appears to be undervalued.
The current stock price of $119.68 is trading 3.6% below its estimated GF Value™ of $124.14.
GuruFocus considers Addus HomeCare to be Fairly Valued.
Key valuation signals for ADUS:
3-Year EBITDA Growth Rate: 18.60% (64% above median its 10-year median of 11.35)
GF Value™: $124.14 vs. price of $119.68 (3.6% below fair value)
Industry Position: 82.4% above the Healthcare Providers & Services median (#188 of 527)
No single metric tells the full story. See the ADUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
95GF Score
Get the complete analysis for ADUS
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADUS has been successfully added to your 
